Filing Flows › Zymeworks (ZYME) › R&D spending
Zymeworks (ZYME) R&D spending by quarter
Zymeworks' R&D spending was $27.4M in Q2 2026 (second quarter 2026), -20% from Q1 2026. Over the last 7 quarters it ranged from $27.4M (Q2 2026) to $37.1M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $27.4M | -20% | -20% |
| Q1 2026 | $34.5M | +10% | -4% |
| Q4 2025 | $31.2M | -12% | -16% |
| Q3 2025 | $35.6M | +3% | — |
| Q2 2025 | $34.4M | -4% | — |
| Q1 2025 | $35.7M | -4% | — |
| Q4 2024 | $37.1M | — | — |
Q2 2026 at a glance
Zymeworks, Q2 2026: revenue $4.6M (-91% year over year), operating margin -919.0%, net loss $45.0M, operating cash flow −$31.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Zymeworks' R&D spending?
Zymeworks' R&D spending was $27.4M in Q2 2026 (second quarter 2026), -20% from Q1 2026.
How has Zymeworks' R&D spending changed?
Over the last 7 quarters it ranged from $27.4M (Q2 2026) to $37.1M (Q4 2024).